Beam Therapeutics News - BEAM

Company Name	Stock Ticker Symbol	Market	Type
Beam Therapeutics Inc	BEAM	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	24.33	07:12:25

Open Price	Low Price	High Price	Close Price	Prev Close
				24.33

more quote information »

Recent News

Date	Time	Source	Heading
3/26/2024	06:30	GLOBE	Beam Therapeutics Announces Clearance of Clinical Trial..
2/28/2024	06:30	GLOBE	Beam Therapeutics to Participate in Upcoming March 2024..
2/27/2024	07:40	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
2/27/2024	07:22	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/27/2024	06:43	EDGAR2	Form 8-K - Current report
2/27/2024	06:30	GLOBE	Beam Therapeutics Reports Fourth Quarter and Year-End 2023..
2/05/2024	06:30	GLOBE	Beam Therapeutics to Participate in the Guggenheim..
2/02/2024	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/02/2024	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/02/2024	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/02/2024	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/02/2024	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/31/2024	16:47	EDGAR2	Form 144 - Report of proposed sale of securities
1/08/2024	06:55	EDGAR2	Form 8-K - Current report
1/08/2024	06:30	GLOBE	Beam Therapeutics Highlights Progress Across Base Editing..
1/05/2024	16:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/02/2024	06:30	GLOBE	Beam Therapeutics to Present at the 42nd Annual J.P. Morgan..
12/14/2023	16:05	EDGAR2	Form 8-K - Current report
12/14/2023	06:30	GLOBE	Beam Therapeutics Appoints Biotech Executive Christi Shaw to..
11/20/2023	16:20	EDGAR2	Form 144 - Report of proposed sale of securities
11/08/2023	07:30	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/2023	07:00	EDGAR2	Form 8-K - Current report
11/08/2023	06:30	GLOBE	Beam Therapeutics Reports Pipeline and Business Updates and..
11/01/2023	16:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/31/2023	06:59	DJN	Beam Therapeutics to Sell Rights in Verve Licensing Deal to..
10/31/2023	06:44	EDGAR2	Form 8-K - Current report
10/31/2023	06:00	GLOBE	Beam Announces Agreement for Lilly to Acquire Beam’s Opt-In..
10/30/2023	16:41	EDGAR2	Form 144 - Report of proposed sale of securities
10/25/2023	06:30	GLOBE	Beam Therapeutics Presents Preclinical Data Highlighting..
10/24/2023	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/19/2023	08:50	EDGAR2	Form 8-K - Current report
10/19/2023	08:45	GLOBE	Beam Therapeutics Announces Portfolio Prioritization and..
10/04/2023	16:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/07/2023	10:00	GLOBE	Beam Therapeutics Presents Preclinical Data Highlighting..
9/05/2023	06:30	GLOBE	Beam Therapeutics Announces First Patient Dosed in Phase 1/2..
8/31/2023	06:30	GLOBE	Beam Therapeutics to Participate in Upcoming September..
8/09/2023	16:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/08/2023	07:30	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/2023	07:11	EDGAR2	Form 8-K - Current report
8/08/2023	06:30	GLOBE	Beam Therapeutics Reports Pipeline Updates and Second..
7/25/2023	18:36	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/21/2023	18:31	EDGAR2	Form 144 - Report of proposed sale of securities
5/17/2023	06:30	GLOBE	Beam Therapeutics to Participate in Upcoming May Investor..
5/11/2023	06:30	GLOBE	Beam Therapeutics to Participate in RBC Capital Markets 2023..
5/10/2023	06:30	GLOBE	Beam Therapeutics Reports Pipeline Updates and First Quarter..